The presence of five cases without CIP2A overexpression and high p-AKT confirmed our previous observations in the cohort of 220 cases about the existence of other molecular mechanisms distinct fromCIP2A involved in p-AKT regulation in breast cancer. Here, CIP2A is linked to breast carcinoma.